BRCA2 and breast carcinoma: Understanding BRCA1/BRCA2 testing rates in breast cancer patients at a higher risk of having pathogenic variants, especially those treated in a community oncology setting where testing rates have traditionally been lower than in academic settings [9], will help inform strategies to improving awareness and testing of BRCA in eligible patients.